Haemonetics Corporation (HAE) NYSE

50.49

+1.59(+3.25%)

Updated at October 03 04:00PM

Currency In USD

Haemonetics Corporation

Address

125 Summer Street

Boston, MA 02110

United States of America

Phone

781 848 7100

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Employees

3657

First IPO Date

May 10, 1991

Key Executives

NameTitlePayYear Born
Mr. Christopher A. SimonChief Executive Officer, President & Director3.6M1964
Ms. Michelle L. Basil J.D.Executive Vice President, General Counsel & Secretary1.24M1972
Mr. James C. D'Arecca CPAChief Financial Officer, Executive Vice President & Financial Officer1.31M1971
Ms. Olga GuyetteSenior Director of Investor Relations0N/A
Ms. Farris Maryanne MaunsellVice President, Chief Accounting Officer & Principal Accounting Officer01976
Mr. Rajeev VarmaSenior Vice President of Strategy & Corporate Development0N/A
Ms. Kerri DiPietroSenior Vice President of Global Quality Assurance0N/A
Mr. Frank W. Chan Ph.D.Executive Vice President & Chief Operating Officer01970
Ms. Laurie A. MillerSenior Vice President & Chief Human Resources Officer01974
Dr. Jan Hartmann M.D.Senior Vice President & Chief Medical Officer0N/A

Description

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.